Skip to content

ΕτικέταCelgene

Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology

  Seattle-based Presage Biosciences made several key moves today that include a $6 million investment from pharma giants Takeda and Celgene and also tapped a new chief executive officer. Presage said the investment from Takeda and Celgene will … Continue Reading Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology

Top 10 M&A Deals of January—June 2018 Value of Mergers and Acquisitions, Volume of Transactions, on Pace to Surpass 2017

    EY’s projection that the volume of mergers and acquisitions (M&A) in “life sciences”—which includes biopharma and medical technology segments—will go well past last year’s $200 billion annual volume of … Continue Reading Top 10 M&A Deals of January—June 2018 Value of Mergers and Acquisitions, Volume of Transactions, on Pace to Surpass 2017

Seattle Cancer Care Alliance One of Only 51 Centers Certified for CAR-T Therapy

    So far there are only two chimeric antigen receptor T-cell (CAR-T) therapies approved by the U.S.Food and Drug Administration (FDA). They are Novartis’ Kymriah (tisagenlecleucel) and Gilead Sciences’ Yescarta (axicabtagene ciloleucel). They have … Continue Reading Seattle Cancer Care Alliance One of Only 51 Centers Certified for CAR-T Therapy